ATE296281T1 - Verwendung von aminen - Google Patents

Verwendung von aminen

Info

Publication number
ATE296281T1
ATE296281T1 AT01926240T AT01926240T ATE296281T1 AT E296281 T1 ATE296281 T1 AT E296281T1 AT 01926240 T AT01926240 T AT 01926240T AT 01926240 T AT01926240 T AT 01926240T AT E296281 T1 ATE296281 T1 AT E296281T1
Authority
AT
Austria
Prior art keywords
combatting
amines
activation
preventing
kinin
Prior art date
Application number
AT01926240T
Other languages
English (en)
Inventor
Anne Juelsrud
Gunn Ragnhild Bjerke
Original Assignee
Amersham Health As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amersham Health As filed Critical Amersham Health As
Application granted granted Critical
Publication of ATE296281T1 publication Critical patent/ATE296281T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Lubricants (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01926240T 2000-03-24 2001-03-22 Verwendung von aminen ATE296281T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0007239.7A GB0007239D0 (en) 2000-03-24 2000-03-24 Use
PCT/NO2001/000123 WO2001072669A2 (en) 2000-03-24 2001-03-22 Therapeutic use of polyhydroxy amine derivates

Publications (1)

Publication Number Publication Date
ATE296281T1 true ATE296281T1 (de) 2005-06-15

Family

ID=9888396

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01926240T ATE296281T1 (de) 2000-03-24 2001-03-22 Verwendung von aminen

Country Status (8)

Country Link
US (1) US7060731B2 (de)
EP (1) EP1282592B1 (de)
JP (1) JP2003528836A (de)
AT (1) ATE296281T1 (de)
AU (1) AU2001252772A1 (de)
DE (1) DE60111044T2 (de)
GB (1) GB0007239D0 (de)
WO (1) WO2001072669A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060100127A1 (en) 2004-11-11 2006-05-11 Meier Ingrid K N,N-dialkylpolyhydroxyalkylamines
US8061515B2 (en) * 2010-02-19 2011-11-22 Michael Carrasquillo Compact disc storage and protective enclosure
JP6415715B2 (ja) * 2015-09-30 2018-10-31 デューク・ユニヴァーシティ アスコルベート製剤及び造影剤としての使用方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2919229A (en) * 1957-11-22 1959-12-29 Us Vitamin Corp N-methylglucamine salts of alphanaphthyl and acyl 1, 3-indandione and methods of using same
US3906109A (en) * 1972-02-09 1975-09-16 Dan Christian Roehm Blood clotting depressant therapy
JPH0678241B2 (ja) * 1986-04-02 1994-10-05 エーザイ株式会社 tPA医薬組成物
US5028625A (en) * 1989-06-20 1991-07-02 American Home Products Corporation Acid addition salt of ibuprofen and meglumine
IL98744A0 (en) * 1990-07-06 1992-07-15 Gen Hospital Corp Method of studying biological tissue using monocrystalline particles
DE69527617T2 (de) * 1994-04-12 2003-04-10 Arakis Ltd., Cambridge Verfahren zur racematspaltung von etodolac unter verwendung von glucamin-derivaten
US5708024A (en) * 1994-06-29 1998-01-13 Novartis Corporation Salts of 2- (2,6-dichlorophenyl)amine!phenylacetoxyacetic acid with organic basic cations
WO1999041233A1 (en) * 1998-02-17 1999-08-19 Micio Pharma Chemical Aktiengesellschaft A watersoluble nimesulide adduct also for injectable use
US6093743A (en) * 1998-06-23 2000-07-25 Medinox Inc. Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor

Also Published As

Publication number Publication date
EP1282592A2 (de) 2003-02-12
DE60111044D1 (de) 2005-06-30
US7060731B2 (en) 2006-06-13
JP2003528836A (ja) 2003-09-30
GB0007239D0 (en) 2000-05-17
US20030045586A1 (en) 2003-03-06
EP1282592B1 (de) 2005-05-25
WO2001072669A3 (en) 2002-01-03
DE60111044T2 (de) 2006-05-04
WO2001072669A2 (en) 2001-10-04
AU2001252772A1 (en) 2001-10-08

Similar Documents

Publication Publication Date Title
BR9916111A (pt) Derivados de fenilglicina
BR9806752A (pt) Ftalazinonas.
ATE336248T1 (de) Verwendung von thiazolidinderivaten als antihyperglykämische mittel
TR200002480T2 (tr) İzaşemi tedavisi için guanidin türevleri
BR0215405A (pt) Composições e processos de uso de collajolie
BR0007527A (pt) Fenilfenantridinas com atividade inibitória depde-iv
ATE355278T1 (de) Isochinolinon derivate als parp inhibitoren
DK0670310T3 (da) Bisulfitaddukt af argininaldehyder egnet som thrombininhibitorer og som antikoagulanter
BR0110998A (pt) Derivados de fenilglicina
UY27972A1 (es) Derivados de hidantoína
DE60121461D1 (de) Kondensierte pyridoindolderivate
BR0111451A (pt) Inibidores de serina protease
NO992492L (no) Benzamidoaldehyder og deres anvendelse som cystein-protease-inhibitorer
DK0998460T3 (da) Hidtil ukendte tetrazolderivater
TR200200883T2 (tr) 2-ikameli 1,1-bifenil-2-karbonamidler, imalat yöntemleri, ilaç olarak kullanılmaları
DE60017878D1 (de) Kombinationspräparate zur behandlung von erkrankungen, die mit angiogenese verbunden sind
WO2002070469A3 (en) Selective pde3b inhibitors and use of the same in therapy
DE60121587D1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
DK1015437T3 (da) Benzoxazin- og benzothiazin-derivater og deres anvendelse i lægemidler
DE50109698D1 (de) N-heteroarylmethyl-m-phenylendiamin-derivate enthaltende färbemittel für keratinfasern sowie neue n-heteroarylmethyl-m-phenylendiamin-derivate
DE60111044D1 (de) Verwendung von aminen
BR0314139A (pt) Derivados de 1,4-pirazina substituìdos
DE60131968D1 (de) PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN
BR9912307A (pt) Inibidores fkbp
DE50111407D1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties